Telemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot Study (TREATS)

Sligo General Hospital

Status

Not yet enrolling

Conditions

Systemic Treatments

Tele-assessment

Rash

Treatments

Other: telem healthassessment

Study type

Interventional

Funder types

Other

Identifiers

NCT07476807

1067SUHREC

Details and patient eligibility

About

This study is being done to find out if video consultations (telemedicine) can be used to safely and effectively assess and manage skin problems caused by cancer treatments. Instead of always coming to the hospital for a face-to-face appointment, the patient may be able to use thier smartphone or computer to show your skin to a nurse or doctor over a secure video call. the researchers want to see if this is as good as a regular clinic visit, and whether patients and staff are happy with this new way of working.

Enrollment

25 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:Participants must meet all of the following criteria:

Adult oncology or haematology patients currently receiving systemic anti-cancer therapy (SACT).
New-onset dermatologic toxicity consistent with a recognised adverse effect of the administered SACT.
Skin toxicity severity graded ≤ Grade 2 in accordance with UKONS assessment criteria.
Clinically stable condition not requiring urgent in-person evaluation.
Access to, and ability to use, a smartphone or computer with adequate internet connectivity to participate in telemedicine consultations.

Exclusion Criteria: Participants will be excluded if any of the following criteria apply:

Skin toxicity graded ≥ Grade 3 according to UKONS assessment criteria.
Clinical status requiring urgent or immediate face-to-face medical assessment.
Dermatologic toxicity that is atypical, unexpected, or not consistent with known SACT-related adverse effects.
Inability to access or effectively use the required telemedicine technology.